摘要
目的研究检测肾细胞癌患者血清铁蛋白水平的临床病理意义。方法采用放射免疫法检测41例肾细胞癌患者血清铁蛋白水平，观察其水平与肿瘤大小、临床分期、组织学类型和肿瘤分化之间的关系。结果肾细胞癌患者血清铁蛋白水平明显高于健康人（P〈0．01），与年龄、性别、组织学类型无关（P〉0．05），与肿瘤大小、临床分期和肿瘤分化有关（P〈0．05）。结论检测肾癌患者血清铁蛋白水平可作为了解肿瘤进展程度和评估病情的参考指标。
Objective To investigate the clinicopathological significance of serum ferritin in patients with renal cell carcinoma. Methods Serum ferritin level were determined in 30 healthy subjects and 41 patients with renal cell carcinoma respectively using radioimmunoassay and its relationship with tumor diameter, stage, histological types and grade. Results Serum ferritin in patients with renal cell carcinoma was much higher than that in healthy subjects （P 〈 0. 01 ） , independent of age, gender and histological types （ P 〉 0.05 ） , and was associated with tumor diameter, stage and tumor differentiation （ P 〈 0. 05 ） . Conclusions Serum ferritin level in patients with renal cell carcinoma might be an reference index for the assessment of tumor progress and disease activity.
出处
《中国实用医刊》
2009年第3期26-27,共2页
Chinese Journal of Practical Medicine
